Insurance Code § 1575.159: COVERAGE FOR PROSTATE-SPECIFIC ANTIGEN TEST
1 bill in the 90th Legislature would change this section
- HB 981 repeals this section
Part of Insurance Code Chapter 1575, with every bill that changes it.
Bills are matched to sections automatically from their text and can be missed, for example when a bill changes a whole chapter at once or renumbers sections. No bill listed here does not mean no bill changes this section.
Current law
Sec. 1575.159. COVERAGE FOR PROSTATE-SPECIFIC ANTIGEN TEST. A health benefit plan offered under the group program, other than a Medicare Advantage plan or a Medicare prescription drug plan, must provide coverage for a medically accepted prostate-specific antigen test used for the detection of prostate cancer for each male enrolled in the health benefit plan who:
(1) is at least 50 years of age; or
(2) is at least 40 years of age and:
(A) has a family history of prostate cancer; or
(B) exhibits another cancer risk factor.
Added by Acts 2001, 77th Leg., ch. 1419, Sec. 3, eff. June 1, 2003.
Amended by:
Acts 2017, 85th Leg., R.S., Ch. 712 (H.B. 3976), Sec. 13, eff. September 1, 2017.
Links
- This chapter as it stands now, Markdown copy of the Texas Legislative Council's statute files
- Official text on statutes.capitol.texas.gov
- RSS feed of actions on these bills
Texas Bill Atlas is an independent research tool, not an official state website.